Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...

Scotiabank lowered the firm’s price target on Kura Oncology (KURA) to $10 from $18 and keeps a Sector Perform rating on the shares. The firm ...

Scotiabank lowered the firm’s price target on Syndax (SNDX) to $16 from $18 and keeps a Sector Perform rating on the shares. The firm adjusted ...

Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...

A British mum has revealed how having puffy eyes ended up being a symptom of a rare form of cancer. Lizzie Spear, 56, had ...

CEO Bruce C. Cozadd sold 1,500 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were ...

Little Aria Stevenson’s smiles are thanks to the kindness of strangers whose blood donations have helped her through ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

Bell had recently teamed up with social media star Quentin Quarantino to raise more than $100K to help pay off people's ...

Researchers sought to determine if HRQoL measures differ with gilteritinib compared with placebo in patients with AML.

Glucarpidase -- a carboxypeptidase enzyme that helps break down and remove methotrexate from the body -- was approved by the ...